Conservative Treatment Of Renal Cell Carcinoma In Kidney Transplantation
ACTAS UROLOGICAS ESPANOLAS(2013)
Abstract
Purpose: To evaluate the new treatment strategies in renal cell carcinoma (RCC) that affects the graft in renal recipients.Acquisition of evidence: A literature review is made, analyzing all the published cases of conservative surgery in renal graft RCC.Synthesis of evidence: A total of 51 partial nephrectomies in renal graft patients have been described, with a graft survival rate of 88% and a recurrence rate of 6%. Most of the patients (75%) were asymptomatic at the time of diagnosis, and the mean lesion size was 2.8 cm. Enucleation was the most frequent technique employed. 77% of all immunosuppressor regimens included cyclosporine A. Six patients with graft RCC were subjected to radiofrequency ablation and two patients underwent percutaneous cryoablation, with a single case of relapse and a graft survival rate of 100%.Conclusions: Nephron-sparing surgery is a good management option in renal graft RCC, affording good oncological control and graft survival. Modification of immunosuppression with the withdrawal of cyclosporine A and the introduction of mTOR inhibitors is an adequate measure in such patients. (C) 2012 AEU. Published by Elsevier Espana, S.L. All rights reserved.
MoreTranslated text
Key words
Kidney transplantation,Partial nephrectomy,Renal cell carcinoma,Cryosurgery,Radiofrequency ablation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined